Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological products
21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological products, “Actions for delays of generic drugs and biosimilar biological products”, is a U.S. Code section of Part A—Drugs and Devices; in force.
https://ontology.bommaritollc.com/id/01a0f06c-ccd8-745e-84b4-4a4530dbb4da
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 U.S.C. 355-2 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Actions for delays of generic drugs and biosimilar biological productsen |
| schema:url | |
| skos:prefLabel | 21 U.S.C. 355-2 Actions for delays of generic drugs and biosimilar biological productsen |